CircSCAF8 promotes growth and metastasis of prostate cancer through the circSCAF8-miR-140-3p/miR-335-LIF pathway

• Published in: Cell death & disease Vol. 13; no. 6; p. 517
• Main Authors: He, Tao, Tao, Wen, Zhang, Lei-Lei, Wang, Bang-Yu, Li, Ke, Lu, Hui-Min, Tang, Guo-Jun, He, Ya-Di, Li, Liao-Yuan
• Format: Journal Article
• Language: English
• Published: England Springer Nature B.V 02.06.2022; Nature Publishing Group UK; Nature Publishing Group
• Subjects: Cell Line, Tumor; Cell migration; Cell proliferation; Cell Proliferation - genetics; Correlation analysis; Extracellular vesicles; Humans; Hyperplasia; Male; Metastases; Metastasis; MicroRNAs - genetics; MicroRNAs - metabolism; Phenotypes; Prostate cancer; Prostatectomy; Prostatic Neoplasms - pathology; RNA, Circular - genetics; Stat3 protein; Tumors
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-022-04913-7

Circular RNAs (circRNAs) have been increasingly linked to cancer progression. However, the detailed biological functions of circRNAs in prostate cancer (PCa) remain unclear. Using high-throughput circRNA sequencing, we previously identified 18 urine extracellular vesicle circRNAs that were increased in patients with PCa compared with those with benign prostatic hyperplasia. Spearman correlation analysis of the expression levels of the 18 circRNAs between the tumor tissue and matched urine extracellular vesicles in 30 PCa patients showed that circSCAF8 had the highest R (R  = 0.635, P < 0.001). The Cox proportional hazards regression model was used to estimate the effect of circSCAF8 on progression-free survival. The in vitro and in vivo functional experiments were implemented to investigate the effects of circSCAF8 on the phenotype of PCa. We found that the knockdown of circSCAF8 in PCa cells suppressed the proliferation, migration, and invasion ability, while overexpression of circSCAF8 had the opposite effects. Similar results were observed in vivo. In a cohort of 85 patients who had undergone radical prostatectomy, circSCAF8 expression in PCa tissues was a powerful predictor of progression-free survival (HR = 2.14, P = 0.022). Mechanistically, circSCAF8 can function by binding to both miR-140-3p and miR-335 to regulate LIF expression and activate the LIF-STAT3 pathway that leads to the growth and metastasis of PCa. Collectively, our findings demonstrate that circSCAF8 contributes to PCa progression through the circSCAF8-miR-140-3p/miR-335-LIF pathway.